Cargando…
Acute intermittent hypoxia drives hepatic de novo lipogenesis in humans and rodents
BACKGROUND AND AIMS: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver condition. It is tightly associated with an adverse metabolic phenotype (including obesity and type 2 diabetes) as well as with obstructive sleep apnoea (OSA) of which intermittent hypoxia is a critical c...
Autores principales: | Hazlehurst, Jonathan M., Lim, Teegan Reina, Charlton, Catriona, Miller, Jack J., Gathercole, Laura L., Cornfield, Thomas, Nikolaou, Nikolaos, Harris, Shelley E., Moolla, Ahmad, Othonos, Nantia, Heather, Lisa C., Marjot, Thomas, Tyler, Damian J., Carr, Carolyn, Hodson, Leanne, McKeating, Jane, Tomlinson, Jeremy W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933516/ https://www.ncbi.nlm.nih.gov/pubmed/35313531 http://dx.doi.org/10.1016/j.metop.2022.100177 |
Ejemplares similares
-
Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis
por: Green, Charlotte J, et al.
Publicado: (2022) -
Sex Differences in Hepatic De Novo Lipogenesis with Acute Fructose Feeding
por: Low, Wee Suan, et al.
Publicado: (2018) -
Sodium‐glucose cotransporter 2 inhibition does not reduce hepatic steatosis in overweight, insulin‐resistant patients without type 2 diabetes
por: Marjot, Thomas, et al.
Publicado: (2019) -
Using total plasma triacylglycerol to assess hepatic de novo lipogenesis as an alternative to VLDL triacylglycerol
por: Hodson, Leanne, et al.
Publicado: (2020) -
Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism
por: Green, Charlotte J, et al.
Publicado: (2020)